Navalign, LLC Zoetis Inc. Transaction History

Navalign, LLC

$301 Million
Q1 2024

A detailed history of Navalign, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Navalign, LLC holds 5,049 shares of ZTS stock, worth $883,373. This represents 0.28% of its overall portfolio holdings.

Number of Shares

5,049

Previous 4,888 3.29%

Holding current value

$883,373

Previous $964,000 11.41%

% of portfolio

0.28%

Previous 0.34%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$165.67 - $199.94 $26,672 - $32,190	161 Added 3.29%	5,049 $854,000
Q4 2023 Jan 18, 2024	BUY	$151.44 - $200.09 $31,499 - $41,618	208 Added 4.44%	4,888 $964,000
Q3 2023 Oct 10, 2023	BUY	$167.14 - $192.77 $1,337 - $1,542	8 Added 0.17%	4,680 $814,000
Q2 2023 Jul 14, 2023	BUY	$160.94 - $186.23 $35,406 - $40,970	220 Added 4.94%	4,672 $804,000
Q1 2023 Apr 19, 2023	BUY	$145.48 - $175.02 $207,890 - $250,103	1,429 Added 47.27%	4,452 $740,000

Q4 2022 Feb 06, 2023	SELL	$131.14 - $157.47 $224,905 - $270,061	-1,715 Reduced 36.2%	3,023 $443,000
Q3 2022 Nov 02, 2022	BUY	$148.29 - $182.55 $20,908 - $25,739	141 Added 3.07%	4,738 $703,000
Q2 2022 Jul 27, 2022	SELL	$155.97 - $200.09 $76,893 - $98,644	-493 Reduced 9.69%	4,597 $790,000
Q1 2022 Apr 29, 2022	SELL	$181.39 - $234.03 $12,153 - $15,680	-67 Reduced 1.3%	5,090 $908,000
Q4 2021 Feb 08, 2022	SELL	$193.69 - $247.03 $58,688 - $74,850	-303 Reduced 5.55%	5,157 $1.26 Million
Q3 2021 Nov 03, 2021	BUY	$189.29 - $209.69 $1.03 Million - $1.14 Million	5,460 New	5,460 $1.06 Million
Q2 2021 Aug 13, 2021	BUY	$155.9 - $187.99 $0 - $0	0 New	0 $978,000

Others Institutions Holding ZTS

# of Institutions

1,860

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.

Account